Five Drugs Panned by FDA Drug Reviewer
Posted on: Friday, 19 November 2004, 18:00 CST
Five drugs cited by a government drug reviewer as the worst examples of those that remain on the market despite safety concerns, along with alternate products:
- Accutane, a treatment for severe acne linked to birth defects and fetal death when used by pregnant women. Alternatives, according to March of Dimes: topical preparations of the antibiotics erythromycin or clindamycin and the antibacterial agent benzoyl peroxide.
- Bextra, a painkiller found in a recent study to more than double the risk of heart attacks and strokes among patients with heart disease. Alternatives, according to Public Citizen: Enteric-coated aspirin or ibuprofen.
- Crestor, an anti-cholesterol drug linked to a muscle-destroying side effect and acute renal failure. Alternative statins: Lipitor, Lescol, Pravachol, Mevacor and Zocor.
- Meridia, an obesity treatment linked to heart problems and, among pregnant women, stillbirths, miscarriages and birth defects. Alternatives: There's no other diet drug that works like Meridia.
- Serevent, an asthma medication that a study in England linked to increased deaths due to asthma. Alternate FDA-approved asthma drugs: Leukotriene blockers, inhaled corticosteroids and theophylline.
Source: Associated Press/AP Online
Related Articles
- Canada studies asthma drug Xolair risks
- FDA: Asthma Drugs Pose No Suicide Risk
- Do Asthma Drugs Worsen Some Diseases?
- Doubt Raised on Drug-Coated Heart Stents
- Expert: Asthma-Drug Warning Being Blown Off
- Inhaled-Insulin Sales Approved BRs Pennington Center Tested Drug, Alternate to Injections
- Asthma Drug Scare at GSK
- FDA Panel: Asthma Drugs Should Stay on Market
- FDA Considers Withdrawal of Asthma Drugs
- Hopes of Cure for Miscarriage; Scientist Uncovers Positive Side-Effect of Asthma Drug
 |
 |
User Comments (0)
RSS Feeds